52 /100
MEDIUM RISK
Score updated Feb 26, 2026
QNCX
Quince Therapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when QNCX's score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
60
📊 Float Risk
90
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market CapN/A
Shares Outstanding55.68M
Float49.76M
CashN/A
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
45 institutional holders · 12.30M shares
#1 Nantahala Capital Management, LLC 3.07M shares
#2 VANGUARD GROUP INC 1.76M shares
#3 MILLENNIUM MANAGEMENT LLC 1.39M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.45M
Days to Cover3.3
% of Float6.9%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2019
Full SEC filing analysis available with free account
📰 Recent News
Track QNCX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNCX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required